Citation: Ak. Fielding et al., ABC OF CLINICAL HEMATOLOGY - THE FUTURE OF HEMATOLOGY, MOLECULAR-BIOLOGY, AND GENE-THERAPY, BMJ. British medical journal, 314(7091), 1997, pp. 1396-1399
Authors:
AGER S
NILSON BHK
MORLING FJ
PENG KW
COSSET FL
RUSSELL SJ
Citation: S. Ager et al., RETROVIRAL DISPLAY OF ANTIBODY FRAGMENTS - INTERDOMAIN SPACING STRONGLY INFLUENCES VECTOR INFECTIVITY, Human gene therapy, 7(17), 1996, pp. 2157-2164
Authors:
JONES N
WILLIAMS D
BROADBENT V
JESTICE K
BORAKS P
SCOTT M
AGER S
MARCUS R
Citation: N. Jones et al., HIGH-DOSE MELPHALAN FOLLOWED BY AUTOGRAFT EMPLOYING NONCRYOPRESERVED PERIPHERAL-BLOOD PROGENITOR CELLS IN CHILDREN, European journal of cancer, 32A(11), 1996, pp. 1938-1942
Authors:
MAHENDRA P
JOHNSON D
SCOTT MA
JESTICE HK
HOOD IM
AGER S
BASS G
BARKER P
BORAKS PA
BLOXHAM DM
BAGLIN TP
MARCUS RE
Citation: P. Mahendra et al., PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE COMPARING 2 MOBILIZATION REGIMENS IN 67 PATIENTS, Bone marrow transplantation, 17(4), 1996, pp. 503-507
Authors:
AGER S
MAHENDRA P
RICHARDS EM
BASS G
BAGLIN TP
MARCUS RE
Citation: S. Ager et al., HIGH-DOSE CARMUSTINE, ETOPOSIDE AND MELPHALAN (BEM) WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION - A DOSE-TOXICITY STUDY, Bone marrow transplantation, 17(3), 1996, pp. 335-340
Authors:
MAHENDRA P
JACOBSON SK
AGER S
BASS G
BARKER P
JOHNSON D
BAGLIN TP
MARCUS RE
Citation: P. Mahendra et al., SHORT-COURSE INTRAVENOUS ANTIBIOTICS WITH ORAL QUINOLONE PROPHYLAXIS IN THE TREATMENT OF NEUTROPENIC FEVER IN AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT RECIPIENTS, Acta haematologica, 96(2), 1996, pp. 64-67
Authors:
SCOTT MA
AGER S
APPERLEY JF
JESTICE HK
BLOXHAM DM
BORAKS P
MAHENDRA P
MARCUS RE
Citation: Ma. Scott et al., PERIPHERAL-BLOOD PROGENITOR-CELL HARVESTING IN MULTIPLE-MYELOMA AND MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 19(5-6), 1995, pp. 479-484
Citation: S. Ager et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR 2ND OR GREATER COMPLETE REMISSION OF ACUTE MYELOID-LEUKEMIA AND ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 18(3-4), 1995, pp. 349-351
Authors:
AGER S
MAHENDRA P
JESTICE HK
SCOTT M
MARCUS RE
Citation: S. Ager et al., THE USE OF NONCRYOPRESERVED PERIPHERAL-BLOOD PROGENITOR CELLS IN AUTOLOGOUS TRANSPLANTATION, Bone marrow transplantation, 16(4), 1995, pp. 633-634
Authors:
AGER S
SCOTT MA
MAHENDRA P
RICHARDS EM
JESTICE HK
BORAKS P
BAGLIN TP
MARCUS RE
Citation: S. Ager et al., PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AFTER HIGH-DOSE THERAPY INPATIENTS WITH MALIGNANT-LYMPHOMA - A RETROSPECTIVE COMPARISON WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 16(1), 1995, pp. 79-83
Authors:
SCOTT MA
AGER S
JESTICE HK
MAHENDRA P
MARCUS RE
Citation: Ma. Scott et al., FAILURE TO MOBILIZE AND HARVEST PBPC DOES NOT NECESSARILY PRECLUDE THE USE OF HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL RESCUE, Bone marrow transplantation, 15(3), 1995, pp. 487-488
Citation: Jr. Macgowan et al., THROMBOCYTOPENIA AND SPONTANEOUS RUPTURE OF THE SPLEEN ASSOCIATED WITH INFECTIOUS-MONONUCLEOSIS, Clinical and laboratory haematology, 17(1), 1995, pp. 93-94
Authors:
MAHENDRA P
AGER S
BEDLOW AJ
BLOXHAM DM
GREEN AR
MARCUS RE
Citation: P. Mahendra et al., 2 UNUSUAL NEUROLOGICAL PRESENTATIONS OF GRANULOCYTIC SARCOMA IN PHILADELPHIA-POSITIVE CHRONIC MYELOID-LEUKEMIA, Leukemia & lymphoma, 15(3-4), 1994, pp. 351-355
Authors:
MAHENDRA P
AGER S
BEDLOW AJ
BLOXHAM DM
GREEN AR
MARCUS RE
Citation: P. Mahendra et al., 2 UNUSUAL NEUROLOGICAL PRESENTATIONS OF GRANULOCYTIC SARCOMA IN PHILADELPHIA-POSITIVE CHRONIC MYELOID-LEUKEMIA, Leukemia & lymphoma, 15(3-4), 1994, pp. 351-355
Authors:
AGER S
WIMPERIS JZ
TOLLIDAY B
JESTICE K
BASS G
BAGLIN T
MARCUS RE
Citation: S. Ager et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS-DISEASE - A 5-YEAR SINGLE-CENTER EXPERIENCE, Leukemia & lymphoma, 13(3-4), 1994, pp. 263-272
Authors:
JESTICE HK
SCOTT MA
AGER S
TOLLIDAY BH
MARCUS RE
Citation: Hk. Jestice et al., LIQUID STORAGE OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR TRANSPLANTATION, Bone marrow transplantation, 14(6), 1994, pp. 991-994
Citation: S. Ager et al., SURVIVAL OUTCOME IN PATIENTS TREATED IN 2ND OR MORE COMPLETE REMISSION WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A COMPARISON BETWEEN ALL AND AML, Experimental hematology, 21(8), 1993, pp. 1063-1063